Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) on Tuesday, soared 7.14% from the previous trading day, before settling in for the closing price of $21.56. Within the past 52 weeks, CPRX’s price has moved between $19.05 and $26.58.
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 34.27%. The company achieved an average annual earnings per share of 20.46%. With a float of $111.90 million, this company’s outstanding shares have now reached $123.26 million.
Catalyst Pharmaceuticals Inc (CPRX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Catalyst Pharmaceuticals Inc is 8.96%, while institutional ownership is 81.33%. The most recent insider transaction that took place on Sep 08 ’25, was worth 609,000. In this transaction Chief Compliance/Legal Officer of this company sold 30,000 shares at a rate of $20.30, taking the stock ownership to the 271,039 shares. Before that another transaction happened on Sep 08 ’25, when Company’s Officer proposed sale 30,000 for $20.30, making the entire transaction worth $609,035.
Catalyst Pharmaceuticals Inc (CPRX) Recent Fiscal highlights
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.7 earnings per share (EPS) for the period topping the consensus outlook (set at 0.55) by 0.15. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.59 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 20.46% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.79% during the next five years compared to 34.27% growth over the previous five years of trading.
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Trading Performance Indicators
Catalyst Pharmaceuticals Inc (CPRX) is currently performing well based on its current performance indicators. A quick ratio of 6.40 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.91. Likewise, its price to free cash flow for the trailing twelve months is 12.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.71, a number that is poised to hit 0.31 in the next quarter and is forecasted to reach 1.79 in one year’s time.
Technical Analysis of Catalyst Pharmaceuticals Inc (CPRX)
Compared to the last year’s volume of 1.37 million, its volume of 1.96 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 57.32%.
During the past 100 days, Catalyst Pharmaceuticals Inc’s (CPRX) raw stochastic average was set at 99.51%, which indicates a significant increase from 99.19% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.80 in the past 14 days, which was higher than the 0.68 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $20.57, while its 200-day Moving Average is $22.04. Nevertheless, the first resistance level for the watch stands at $23.64 in the near term. At $24.18, the stock is likely to face the second major resistance level. The third major resistance level sits at $25.24. If the price goes on to break the first support level at $22.04, it is likely to go to the next support level at $20.98. Now, if the price goes above the second support level, the third support stands at $20.44.
Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) Key Stats
Market capitalization of the company is 2.84 billion based on 122,912K outstanding shares. Right now, sales total 491,730 K and income totals 163,890 K. The company made 148,390 K in profit during its latest quarter, and 52,780 K in sales during its previous quarter.
